EP Patent

EP4392097A1 — Autoinjector

Assigned to Medmix Switzerland AG · Expires 2024-07-03 · 2y expired

What this patent protects

The present invention relates to an autoinjector (10), the autoinjector comprising a housing (12), a needle guard (18) mounted axially moveable in the housing for movement between a storage state, a dispensing state and a lock-out state in which states the needle guard adopts dif…

USPTO Abstract

The present invention relates to an autoinjector (10), the autoinjector comprising a housing (12), a needle guard (18) mounted axially moveable in the housing for movement between a storage state, a dispensing state and a lock-out state in which states the needle guard adopts different axial positions relative to the housing, with the needle guard being configured to be axially moved in a proximal direction between the dispensing state and the lock-out state.

Drugs covered by this patent

Patent Metadata

Patent number
EP4392097A1
Jurisdiction
EP
Classification
Expires
2024-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Medmix Switzerland AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.